Director, National Payer Accounts

Cogent Biosciences • Waltham, MA, US • published 2026-09-22 23:43:00.309460

Description

**Who We Are:** Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600\+ patients in single agent and combination dosing. **The Role:** **Position Overview:** * The Director, National Payer Accounts, is responsible for ensuring profitable coverage access with government accounts and key regional plans. * Supporting execution of the Market Access objectives and strategy for the payer audience. * Collaborating with internal partners but not limited to Market Access, Market...

Get jobs like this daily in Telegram: @careeri_bot